Next generation sequencing Archives

Switzerland Hôpitaux Universitaires Genève HUG

News and Trends 11 Sep 2019

IBM’s Watson for Genomics Launches in First European Hospital

The Hôpitaux Universitaires Genève in Switzerland will be the first European university hospital to implement IBM’s artificial intelligence to help doctors select treatments for complex cancer cases. “Artificial intelligence could empower our clinicians to increase the speed of diagnosing their patients,” said Rodolphe Meyer, who is responsible for the IT department of […]

September 11, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

adc therapeutics genomics sophia genetics blood cancer

News and Trends 6 Aug 2019

ADC Therapeutics and SOPHiA Genetics Team Up to Personalize Cancer Treatment

Two companies based in Lausanne, Switzerland — ADC Therapeutics and the genomics company SOPHiA Genetics — have signed a deal to identify patients most likely to respond to a blood cancer drug. ADC Therapeutics will send SOPHiA Genetics blood samples collected from an ongoing phase II trial. The trial is testing a treatment for patients […]

August 6, 2019 - 2 minutesmins - By Jonathan Smith

omics aromics barcelona panorama mesothelioma

Startup Scout 12 Jul 2019

This Biotech Uses ‘Omics’ to Develop Treatments for Drug-Resistant Cancer

Next time you travel to Barcelona, Spain, check out Aromics, a biotech that is using genomics and proteomics to develop treatments for cancers such as malignant mesothelioma, which can be caused by asbestos. Mission: To use omics technology to treat drug-resistant cancers, as well as to identify cancer biomarkers that could improve monitoring in clinical […]

July 12, 2019 - 3 minutesmins - By Jonathan Smith

Startup Scout 17 May 2019

This Biotech Detects Fraudulent Food by Checking its DNA

Spun out of the University of Milano-Bicocca, the Italian biotech Fem2-Ambiente aids in the fight against food contamination and fraud by sequencing DNA traces from food samples. Mission: To use DNA barcoding to make sure that foods are free from contamination, such as fraudulent ingredients, microbes or allergenic particles. Food fraud is a crime where […]

May 17, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 1 May 2019

UK Genome Diagnostics Biotech Closes €27M Series B to Support NHS

Cambridge-based Congenica has closed a €27M (£23.3M) series B fundraising round to support the use of its rare disease diagnostics platform by the newly formed NHS Genomic Medicine Service, as well as to allow the company to expand internationally. The genomics diagnostic company received a €15.5M (£13.3M) investment, led by the London-based fund management firm […]

May 1, 2019 - 2 minutesmins - By Helen Albert

sophia genetics ai genomics cancer diagnostic

News and Trends 11 Apr 2019

Swiss Multi-Cancer Diagnostic Test Approved in Europe

A cancer test developed by the Swiss company SOPHiA GENETICS has been approved for diagnosing multiple types of solid tumors by looking at genetic variations in 42 genes. SOPHiA GENETICS works in data-driven medicine, using huge amounts of genomic data to diagnose and personalize treatments to a patient. This new technology is being adopted by […]

April 11, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 21 Mar 2019

UK Government’s Bid on Healthcare Genomics Already Benefiting Biotechs

The positive stance of the UK Government towards incorporation of genomics into healthcare has created unparalleled chances for the country’s biotech companies, which are already taking advantage of the business opportunities. Following the completion of the 100,000 Genomes Project at the end of 2018, the fledgling NHS Genomic Medicine Service launched. This service aims to […]

March 21, 2019 - 5 minutesmins - By Helen Albert

Next generation sequencing Nick McCooke Solexa DNA electronics

Interview 11 Mar 2019

The Man Behind Next-Generation Sequencing

Nick McCooke shares the story behind the invention of next-generation sequencing at Solexa and his latest adventure in the sequencing world with the company DNA Electronics. Nick McCooke led the pioneer team at Solexa that invented next-generation sequencing, a technology to read DNA at high speed that is nowadays used worldwide and has laid the […]

March 11, 2019 - 9 minutesmins - By Clara Rodríguez Fernández

stem cell therapy mogrify disley heart disease

Startup Scout 22 Feb 2019

This Biotech’s Algorithm Accelerates Cell Therapy Development

Mogrify is the new kid on the block for cell therapy. Based in Cambridge, UK, it boasts technology that could speed up the development of cell therapies by predicting the best chemical recipe to transform mature adult cells into other cell types. Mission: To use next-generation sequencing and gene expression data to develop more cost-effective […]

February 22, 2019 - 3 minutesmins - By Jonathan Smith

antibiotic resistance next generation sequencing ares qiagen 1

News and Trends 21 Feb 2019

Qiagen Gets Access to Largest Genetic Database on Antibiotic Resistance

Under a new licensing deal, Qiagen will gain access to a big genetics database from Vienna-based Ares Genetics, which could help tackle the global health crisis of antibiotic resistance. Antibiotic resistance is a major health concern that is growing fast. One reason for this is that people are often prescribed the wrong antibiotic for […]

February 21, 2019 - 3 minutesmins - By Jonathan Smith

Best in Biotech 18 Feb 2019

10 European Genomics Companies to Watch Out For

Next generation sequencing has revolutionized the biotech industry and genomics technology has changed dramatically over the last few years. There are many interesting European genomics companies, but here are 10 we thought especially worthy of mention. By 2025, the size of global genomics market is predicted to reach a whopping €24B, and unsurprisingly, there’s a […]

February 18, 2019 - 8 minutesmins - By David Cox

medical university of vienna kidney transplant genomics

News and Trends 15 Feb 2019

Genetic Testing Improves Success of Kidney Transplants

Genetic variations in cell surface proteins are able to predict kidney transplant success, shows Austrian research, serving as a potential screening tool for improving future transplants. Many kidney transplants fail over time because the patient’s immune system rejects the organ. This rejection happens because the immune system recognizes that particular proteins on the cell surface, such […]

February 15, 2019 - 2 minutesmins - By Jonathan Smith

Resources

Categories

The biggest private biotech investments in August 2024

Long non-coding RNAs: what’s behind the growing “dark genome” buzz?

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Six biotech companies that could revolutionize obesity treatments

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us